For example, no study we reviewed here assessed specific populations such as indigenous peoples. Similarly, while women were often excluded by the study design, no study examined only women. It is unknown how generalisable any of the results reviewed here are outside of the context in which they were conducted, and it is unwise therefore to combine results across populations.
S1 Data. Open data extraction.
In addition to not being widely available 117, a limitation of behavioral therapies is the finding that they have moderate and variable efficacy in terms of abstinence and retention and still result in limited long-term recovery and subsequently relapse. This data underscores the need for additional efficacious therapies, such as pharmacotherapies, to help relieve withdrawal symptoms and support motivation for METH-dependent individuals to stay abstinent. Scientific evidence supports CM as the choice of non-pharmacological treatment followed by CBT and then rTMS/tDCS. There was no difference in MA use by UDS in the treatment arm compared with placebo in the extended-release studies 29, 56.
Meth Addiction Treatment and Rehab Programs Near Me
- However, glucocorticoid receptor antagonists such as mifepristone also displayed significant negative connectivity scores with the BA9 expression signature supporting previous findings.
- Furthermore, StUD can lead to a plethora of long-term health problems, including cardiac, pulmonary, psychiatric, dental, nutritional, skin, and cognitive issues.
The emergence of this guideline follows a concerning increase in overdose deaths involving stimulant drugs, including cocaine, methamphetamine, amphetamine, and prescription stimulants, over the past decade. Between 2012 and 2021, overdose deaths from these substances rose alarmingly, with rates involving cocaine more than tripling, and deaths involving methamphetamine, amphetamine, and prescription stimulants increasing even more dramatically. Furthermore, StUD can lead to a plethora of long-term health problems, including cardiac, pulmonary, psychiatric, dental, nutritional, skin, and cognitive issues. The dopaminergic system has been a favored target for MUD pharmacotherapy, and several medications that target dopamine transporter or dopamine D2 receptor have been tested in clinical trials. Agonists for dopamine receptors mimic the action of monoamines to provide modest levels of METH reward/reinforcement.
Substances
CM plus CBT, CM, and 12-step programme were superior to TAU in terms of abstinence at the end of treatment, while Amphetamine Addiction CBT, CM, and the combination of CM plus community reinforcement approach were superior to TAU in terms of dropout at the end of treatment (S4 Table). Eight psychosocial interventions had at least 1 trial versus TAU, and all of them were directly compared with at least another psychosocial intervention. We obtained unpublished or supplementary information for 5 of the included studies 45,49,59–61. Future research should address small sample sizes and low participant retention and treatment adherence rates, leading to underpowered studies lacking meaningful results.
- Forty (93.0%) of these studies were double-blinded 24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45, 47,48,49,50,51,52,53,54,55, 57,58,59,60,61,62,63,64,65.
- Amineptine was found to have limited benefits, showing improvement only on some subjective effects but is no longer on the market because of concerns over its abuse liability.
- There was no difference in MA use by UDS in the treatment arm compared with placebo in the extended-release studies 29, 56.
Three studies performed a last observation carried forward method of intent‐to‐treat analysis and one study had a drop out rate that was balanced across intervention groups. Test of heterogeneity is important to check whether the results of studies are similar within each comparison. The reviewers checked whether differences between the results of trials were greater than could be expected by chance alone. This was done by looking at the graphical display of the results but also by using Chi square tests of heterogeneity. A p‐value being less than 0.05 of a Chi‐square test was indicated the significant heterogeneity of a data set. The statistical methods for dealing with a data set with significant and non significant heterogeneity were described in ‘Data synthesis’.
